BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20356403)

  • 1. Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.
    Redshaw Z; Strain AJ
    J Negat Results Biomed; 2010 Mar; 9(1):2. PubMed ID: 20356403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
    Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
    J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
    Lin H; Shabbir A; Molnar M; Lee T
    Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT4 pseudogenes present in human leukemia cells.
    Guo X; Tang Y
    Clin Exp Med; 2012 Dec; 12(4):207-16. PubMed ID: 22086193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of POU5F1 (OCT4) gene and its promoter in buffalo ESC-like cells identifies multiple transcription start sites and expression of four pseudogenes.
    Singh N; George A; Sharma R; Singla SK; Palta P; Manik R; Chauhan MS; Singh D
    Gene; 2012 Jan; 491(2):165-72. PubMed ID: 22019428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of the Oct4 extended transcriptional regulatory region in Guanzhong dairy goat.
    Cheng X; Meng S; Deng J; Lai W; Wang H
    Genome; 2011 Oct; 54(10):812-8. PubMed ID: 21929360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells.
    Jung M; Peterson H; Chavez L; Kahlem P; Lehrach H; Vilo J; Adjaye J
    PLoS One; 2010 May; 5(5):e10709. PubMed ID: 20505756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4 pseudogenes are transcribed in cancers.
    Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
    Liedtke S; Stephan M; Kögler G
    Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.
    Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T
    PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
    Xu G; Yang L; Zhang W; Wei X
    Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
    Poursani EM; Mohammad Soltani B; Mowla SJ
    Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
    Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
    Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells.
    Yang J; Gao C; Chai L; Ma Y
    PLoS One; 2010 May; 5(5):e10766. PubMed ID: 20505821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Oct4 overproduction in mouse embryonic stem cells results in prolonged mesoderm commitment during hematopoietic differentiation in vitro.
    Camara-Clayette V; Le Pesteur F; Vainchenker W; Sainteny F
    Stem Cells; 2006 Aug; 24(8):1937-45. PubMed ID: 16690781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development.
    Monk M; Hitchins M; Hawes S
    Mol Hum Reprod; 2008 Jun; 14(6):347-55. PubMed ID: 18467432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved roles for Oct4 homologues in maintaining multipotency during early vertebrate development.
    Morrison GM; Brickman JM
    Development; 2006 May; 133(10):2011-22. PubMed ID: 16651543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for isolating pluripotent/multipotent stem cells from blood by using the pluripotent and germ-line DAZL gene as a marker.
    Seligman J; Slavin S; Fabian I
    Stem Cells Dev; 2009 Nov; 18(9):1263-71. PubMed ID: 19327014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.
    Scarola M; Comisso E; Pascolo R; Chiaradia R; Marion RM; Schneider C; Blasco MA; Schoeftner S; Benetti R
    Nat Commun; 2015 Jul; 6():7631. PubMed ID: 26158551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.